Email this article 
Determination Pattern of Antimicrobial Resistance of Pseudomonas Isolated from Patients in a University Tertiary Hospital
Abstract
Introduction: Pseudomonas are ubiquitous bacteria widely present in nature. However, they have emerged as an opportunistic pathogen for humans. This bacterium is accountable for many localized and disseminated diseases, especially wounds in burn patients, respiratory infections, septicemia and bacteremia. Among all Pseudomonas species, P. aeruginosa is one of the important and most virulent species in hospital settings, while other pathogenic species include stutzeri, putida and fluorescence. The aim of this study was to assess pattern of antibiotic resistance in these bacteria isolated from a University teaching and treatment center. This cross-sectional study was conducted on 99 Pseudomonas strains (68 strains P. aeruginosa and 31 other Pseudomonas species) isolated from various clinical specimens. Antimicrobial drug susceptibility test was performed using the disc agar diffusion method according to CLSI recommendations. In this study, among various clinical specimens sent to microbiology laboratory, wound (59.59%) was found as a major source of Pseudomonas spp. Among various wards, Pseudomonas spp. was isolated more from patients admitted to burns ward (48.48%). Antibiotic susceptibility assay results revealed non susceptibility pattern towards most of the antibiotics; however, among all antibiotics tested, most common resistance was observed towards ceftazidime (76.76%). The results of this study shows the presence of Pseudomonas infection in the hospital setting and their developed resistance towards many conventional antibiotics, which is a concern at this treatment center. Thus, there exist a need for evaluation of careful and accurate measurement of resistance and assessment of exact drug administration policies. Therefore, to control the infection and prevent from increased prevalence of resistant strains appropriate resolution should be followed.
Keywords
Full Text:
PDFReferences
El-Rehewy MS, Saboor EA, Afifi NA, Ibrahim MA, Qayed SS. Detection and Characterization of Nosocomial Carbapenem-Resistant Gram Negative Bacilli from Assuit University Hospitals. The Egyptian Journal of Medical Microbiology (EJMM). 2016 Jul 19;25(3).
Leylabadlo HE, Kafil HS, Yousefi M, Aghazadeh M, Asgharzadeh M. Persistent infection with metallo-beta-lactamase and extended spectrum β-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation. Journal of natural science, biology, and medicine. 2016;7(2):179.
Qiu D, Eisinger VM, Rowen DW, Hongwei DY. Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences. 2007;104(19):8107-12.
Cross A, Allen JR, Burke J, Ducel G, Harris A, John J, et al. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Review of Infectious Diseases. 1983;5(Supplement 5):S837-S45.
Leylabadlo HE, Kafil HS, Aghazadeh M, Hazratian T. Nosocomial oral myiasis in ICU patients: occurrence of three sequential cases. GMS hygiene and infection control. 2015;10.
Moolenaar RL, Crutcher JM, San Joaquin VH, Sewell LV, Hutwagner LC, Carson LA, et al. A Prolonged Outbreak of Pseudomonas Aeruginosa in a Neonatal Intensive Care Unit Did Staff Fingernails Play a Role in Disease Transmission? Infection Control & Hospital Epidemiology. 2000;21(02):80-5.
Zaborina O, Kohler JE, Wang Y, Bethel C, Shevchenko O, Wu L, et al. Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier. Annals of clinical microbiology and antimicrobials. 2006;5(1):1.
Eriksen H, Iversen B, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. Journal of Hospital Infection. 2005;60(1):40-5.
Taylor G, Kibsey P, Kirkland T, Burroughs E, Tredget E. Predominance of staphylococcal organisms in infections occurring in a burns intensive care unit. Burns. 1992;18(4):332-5.
Leylabadlo HE, Asgharzadeh M, Aghazadeh M. Dissemination of carbapenemases producing Gram negative bacteria in the Middle East. Iranian journal of microbiology. 2015;7(5):226.
Nicas TI, Iglewski BH. Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S. Infection and immunity. 1984;45(2):470-4.
Kitao T, Tada T, Tanaka M, Narahara K, Shimojima M, Shimada K, et al. Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC (6′)-Iae in Japan. International journal of antimicrobial agents. 2012;39(6):518-21.
Hota S, Hirji Z, Stockton K, Lemieux C, Dedier H, Wolfaardt G, et al. Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infection Control & Hospital Epidemiology. 2009;30(01):25-33.
Jorgensen JH, Turnidge JD. Susceptibility test methods: dilution and disk diffusion methods. Manual of Clinical Microbiology, Eleventh Edition: American Society of Microbiology; 2015. p. 1253-73.
Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrobial agents and chemotherapy. 2010;54(1):109-15.
Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs. 2007;67(3):351-68.
Babay HAH. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005. Japanese journal of infectious diseases. 2007;60(2/3):123.
Yüce A, Yapar N, Eren KO. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir]. Mikrobiyoloji bulteni. 2009;43(2):195-202.
Nordmann P, Guibert M. Extended-spectrum β-lactamases in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 1998;42(2):128-31.
Rossolini G, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clinical Microbiology and Infection. 2005;11(s4):17-32.
Khosravi AD, Mihani F. Detection of metallo-β-lactamase–producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Diagnostic microbiology and infectious disease. 2008;60(1):125-8.
Moniri R, Mosayebi Z, Movahedian A. Increasing trend of antimicrobial drug-resistance in Pseudomonas aeruginosa causing septicemia. Iranian Journal of Public Health. 2006;35(1):58-62.
Ekrami A, Kalantar E. Bacterial infections in burn patients at a burn hospital in Iran. Indian Journal of Medical Research. 2007;126(6):541.
Nehme D, Poole K. Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors. Journal of bacteriology. 2007;189(17):6118-27.
Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance]. Medicina (Kaunas, Lithuania). 2008;45(1):1-7.
Alişkan H, Colakoğlu S, Turunç T, Demiroğlu Y, Erdoğan F, Akin S, et al. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Mikrobiyoloji bulteni. 2008;42(2):321-9.
DOI: https://doi.org/10.7575/aiac.abcmed.17.05.03.03
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
2013-2023 (CC-BY) Australian International Academic Centre PTY.LTD.
Advances in Bioscience and Clinical Medicine